Physician profile
Amanda Thistle
NPI 1891076758
$1,077.85
in general payments reported to CMS, 2019-2025
11 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $212 · 2023: $250 · 2024: $175 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $586.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $586.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $412.72 | 2021-2025 | |
| Merck Sharp & Dohme LLC | $280.84 | 2021-2025 | Vaxneuvance, Vaxelis, Gardasil 9 |
| Sanofi Pasteur INC. | $125.28 | 2022-2025 | |
| Astrazeneca Pharmaceuticals LP | $59.22 | 2023-2024 | Flumist Quadrivalent |
| Kaleo, INC. | $53.27 | 2021-2024 | Auvi-Q |
| Kowa Pharmaceuticals America, INC. | $45.76 | 2024-2025 | Zoryve |
| Cranial Technologies, INC | $38.29 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $24.70 | 2023 | Dupixent |
| Becton, Dickinson and Company | $17.68 | 2022 | |
| Alk-Abello, INC | $15.50 | 2025 | Neffy |
| Genentech USA, INC. | $4.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Thistle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.